TY - JOUR
T1 - The relationship between pre-existing diabetes mellitus and the severity of acute pancreatitis
T2 - Report from a large international registry: Diabetes Mellitus in Acute Pancreatitis
AU - Paragomi, Pedram
AU - Papachristou, Georgios I.
AU - Jeong, Kwonho
AU - Hinton, Alice
AU - Pothoulakis, Ioannis
AU - Talukdar, Rupjyoti
AU - Kochhar, Rakesh
AU - Goenka, Mahesh K.
AU - Gulla, Aiste
AU - Gonzalez, Jose A.
AU - Singh, Vikesh K.
AU - Ferreira Bogado, Miguel
AU - Stevens, Tyler
AU - Barbu, Sorin T.
AU - Nawaz, Haq
AU - Gutierrez, Silvia C.
AU - Zarnescu, Narcis
AU - Archibugi, Livia
AU - Easler, Jeffrey J.
AU - Triantafyllou, Konstantinos
AU - Peláez-Luna, Mario
AU - Thakkar, Shyam
AU - Ocampo, Carlos
AU - de-Madaria, Enrique
AU - Cote, Gregory A.
AU - Wu, Bechien U.
AU - Lee, Peter J.
AU - Hart, Phil A.
AU - Conwell, Darwin L.
AU - Toledo, Frederico G.S.
AU - Yadav, Dhiraj
N1 - Funding Information:
Research reported in this publication was supported under award numbers - U01 DK108306 (DY) by the National Cancer Institute (NCI) and NIDDK - U01DK108306 and U01DK127377 (DY), the Department of Defense – DoD PR 182623 (DY), U01DK127388 (GIP, DLC), U01DK127400 (VKS), U01DK127377 (FGST), and NIH T32CA186873 (PP) training grant in cancer epidemiology and prevention. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Defense. All the other authors have no disclosures.
Publisher Copyright:
© 2021
PY - 2022/1
Y1 - 2022/1
N2 - Background/Objectives: The relationship between pre-existing diabetes mellitus (DM) and acute pancreatitis (AP) severity has not been established. We assessed the impact of pre-existing DM on AP severity in an international, prospectively ascertained registry. Methods: APPRENTICE registry prospectively enrolled 1543 AP patients from 22 centers across 4 continents (8 US, 6 Europe, 5 Latin America, 3 India) between 2015 and 2018, and collected detailed clinical information. Pre-existing DM was defined a diagnosis of DM prior to AP admission. The primary outcome was AP severity defined by the Revised Atlanta Classification (RAC). Secondary outcomes were development of systemic inflammatory response syndrome (SIRS) or intensive care unit (ICU) admission. Results: Pre-existing DM was present in 270 (17.5%) AP patients, of whom 252 (93.3%) had type 2 DM. Patients with pre-existing DM were significantly (p < 0.05) older (55.8 ± 16 vs. 48.3 ± 18.7 years), more likely to be overweight (BMI 29.5 ± 7 vs. 27.2 ± 6.2), have hypertriglyceridemia as the etiology (15% vs. 2%) and prior AP (33 vs. 24%). Mild, moderate, and severe AP were noted in 66%, 23%, and 11% of patients, respectively. On multivariable analysis, pre-existing DM did not significantly impact AP severity assessed by the RAC (moderate-severe vs. mild AP, OR = 0.86, 95% CI 0.63–1.18; severe vs. mild-moderate AP, OR = 1.05, 95% CI, 0.67–1.63), development of SIRS, or the need for ICU admission. No interaction was noted between DM status and continent. Conclusion: About one in 5 patients with AP have pre-existing DM. Once confounding risk factors are considered, pre-existing DM per se is not a risk factor for severe AP.
AB - Background/Objectives: The relationship between pre-existing diabetes mellitus (DM) and acute pancreatitis (AP) severity has not been established. We assessed the impact of pre-existing DM on AP severity in an international, prospectively ascertained registry. Methods: APPRENTICE registry prospectively enrolled 1543 AP patients from 22 centers across 4 continents (8 US, 6 Europe, 5 Latin America, 3 India) between 2015 and 2018, and collected detailed clinical information. Pre-existing DM was defined a diagnosis of DM prior to AP admission. The primary outcome was AP severity defined by the Revised Atlanta Classification (RAC). Secondary outcomes were development of systemic inflammatory response syndrome (SIRS) or intensive care unit (ICU) admission. Results: Pre-existing DM was present in 270 (17.5%) AP patients, of whom 252 (93.3%) had type 2 DM. Patients with pre-existing DM were significantly (p < 0.05) older (55.8 ± 16 vs. 48.3 ± 18.7 years), more likely to be overweight (BMI 29.5 ± 7 vs. 27.2 ± 6.2), have hypertriglyceridemia as the etiology (15% vs. 2%) and prior AP (33 vs. 24%). Mild, moderate, and severe AP were noted in 66%, 23%, and 11% of patients, respectively. On multivariable analysis, pre-existing DM did not significantly impact AP severity assessed by the RAC (moderate-severe vs. mild AP, OR = 0.86, 95% CI 0.63–1.18; severe vs. mild-moderate AP, OR = 1.05, 95% CI, 0.67–1.63), development of SIRS, or the need for ICU admission. No interaction was noted between DM status and continent. Conclusion: About one in 5 patients with AP have pre-existing DM. Once confounding risk factors are considered, pre-existing DM per se is not a risk factor for severe AP.
KW - Diabetes
KW - Etiology
KW - Hospitalization
KW - Mortality
KW - Pancreatitis
KW - Prevalence
UR - http://www.scopus.com/inward/record.url?scp=85117204061&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117204061&partnerID=8YFLogxK
U2 - 10.1016/j.pan.2021.10.001
DO - 10.1016/j.pan.2021.10.001
M3 - Article
C2 - 34656431
AN - SCOPUS:85117204061
SN - 1424-3903
VL - 22
SP - 85
EP - 91
JO - Pancreatology
JF - Pancreatology
IS - 1
ER -